Optimization of the microencapsulated islet for transplantation

Area of Science:

• Biomaterials Science
• Cell Encapsulation Technology
• Islet Transplantation Research

Background:

• Microencapsulation of islets offers immune protection for transplantation.
• Current methods use alginate-calcium core chelation, potentially compromising capsule integrity and durability.
• Investigating non-chelated microencapsulation is crucial for improved islet viability and function.

Purpose of the Study:

• To evaluate the in vitro glucose-stimulated insulin response of microencapsulated islets without core chelation.
• To compare the functional outcomes of chelated versus unchelated microencapsulated islets.
• To determine the necessity of chelation for maintaining islet function post-encapsulation.

Main Methods:

• Islets from Sprague-Dawley rats were microencapsulated in alginate using an air-jet-syringe-pump droplet generator.
• Microcapsules underwent poly-L-lysine and alginate coating.
• Glucose stimulation tests (16.7 mM) were performed on chelated, unchelated, and cultured unchelated microencapsulated islets.

Main Results:

• Chelated microencapsulated islets exhibited a normal biphasic insulin response to glucose, similar to unencapsulated controls.
• Unchelated microencapsulated islets showed no significant response to glucose stimulation.
• A minor but significant insulin response was observed in unchelated microcapsules after 24-hour culture.

Conclusions:

• Core chelation is essential for achieving optimal glucose-stimulated insulin secretion in microencapsulated islets.
• While culturing may partially restore function, it does not fully compensate for the lack of chelation.
• These findings highlight the critical role of the chelation process in maintaining islet viability and function within microcapsules.